| Current Price | $49.30 | Mkt Cap | $2.88B |
|---|---|---|---|
| Open | $49.12 | P/E Ratio | 16.80 |
| Prev. Close | $49.41 | Div. (Yield) | N/A (N/A) |
| Daily Range | $48.98 - $49.59 | Volume | 139,749 |
| 52-Wk Range | $36.55 - $70.74 | Avg. Daily Vol. | 0 |
News & Discussion Boards
- Implied Stock-Price Moves for U.S. Companies Reporting Results 2/10/2012 8:04:43 AM -
- United Therapeutics Corporation to Announce Fourth Quarter and Annual 2011 Financial Results Before Market Open on Tuesday, February 14, 2012 2/7/2012 7:00:00 AM -
- United Therapeutics Receives Paragraph IV Notice Letter for Remodulin 2/6/2012 7:00:00 AM -
- United Therapeutics Drops on Generic Drug: Washington Mover 1/24/2012 2:51:07 PM -
- United Therapeutics Earnings Preview 2/9/2012 1:26:36 PM
- United Therapeutics Earnings Preview 2/9/2012 1:26:36 PM
- Generic Challenge for UTHR's Remodulin - Analyst Blog 2/8/2012 3:36:01 PM
- United Therapeutics Passes This Key Test 12/30/2011 11:27:29 AM
| Subject | Recs | Author | Date |
|---|


